Buffington Mohr Mc Neal Exact Sciences Corp Call Options Transaction History
Buffington Mohr Mc Neal
- $505 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
660Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.22 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$808 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$804 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...